US 9567402
Internalizing human monoclonal antibodies targeting prostate and other cancer cells
granted A61KA61K47/6811A61K47/6829
Quick answer
US patent 9567402 (Internalizing human monoclonal antibodies targeting prostate and other cancer cells) held by The Regents of the University of California expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K47/6811, A61K47/6829, A61K47/6849, A61K47/6869